Literature DB >> 19597708

Cyclooxygenase-2 immunoreactivity and protein level in the gerbil hippocampus during normal aging.

Choong Hyun Lee1, Ki-Yeon Yoo, Jung Hoon Choi, Ok Kyu Park, In Koo Hwang, Il-Jun Kang, Moo-Ho Won.   

Abstract

Cyclooxygenases-2 (COX-2) is not only related to inflammation but also plays critical roles in brain development and synaptic signaling. In the present study, we investigated age-related changes in COX-2 immunoreactivity and protein levels in the gerbil hippocampus. In the hippocampal CA1 region (CA1) and dentate gyrus (DG), weak COX-2 immunoreactivity was observed at postnatal month 1 (PM 1), and COX-2 immunoreactivity was markedly increased at PM 18 and 24. In the CA2/3, COX-2 immunoreactivity was strong at PM 1. COX-2 immunoreactivities in the PM 3, 6 and 12 groups were decreased compared to that in the PM 1 group, and it was increased at PM 18 and 24. In addition, age-related changes in COX-2 levels were similar with immunohistochemical results in the CA2/3. These results suggest that COX-2 immunoreactivity and levels were high in the hippocampus of aged gerbils.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597708     DOI: 10.1007/s11064-009-0034-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  36 in total

1.  Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease.

Authors:  J G Sheng; R E Mrak; C R Rovnaghi; E Kozlowska; L J Van Eldik; W S Griffin
Journal:  Neurobiol Aging       Date:  1996 May-Jun       Impact factor: 4.673

Review 2.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

3.  Characterization of inducible cyclooxygenase in rat brain.

Authors:  C D Breder; D Dewitt; R P Kraig
Journal:  J Comp Neurol       Date:  1995-05-01       Impact factor: 3.215

4.  Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia.

Authors:  C Iadecola; C Forster; S Nogawa; H B Clark; M E Ross
Journal:  Acta Neuropathol       Date:  1999-07       Impact factor: 17.088

5.  Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.

Authors:  M Nakayama; K Uchimura; R L Zhu; T Nagayama; M E Rose; R A Stetler; P C Isakson; J Chen; S H Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  Assessment of the relative contribution of COX-1 and COX-2 isoforms to ischemia-induced oxidative damage and neurodegeneration following transient global cerebral ischemia.

Authors:  Eduardo Candelario-Jalil; Armando González-Falcón; Michel García-Cabrera; Dalia Alvarez; Said Al-Dalain; Gregorio Martínez; Olga Sonia León; Joe E Springer
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

7.  Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids.

Authors:  K Yamagata; K I Andreasson; W E Kaufmann; C A Barnes; P F Worley
Journal:  Neuron       Date:  1993-08       Impact factor: 17.173

8.  Prevention of age-related changes in rat cortex transcription factor activator protein-1 by hypolipidemic drugs.

Authors:  Elena Sanguino; Núria Roglans; Marta Alegret; Rosa M Sánchez; Manuel Vázquez-Carrera; Juan C Laguna
Journal:  Biochem Pharmacol       Date:  2004-10-01       Impact factor: 5.858

9.  Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction.

Authors:  Sylvain Doré; Takashi Otsuka; Toshiaki Mito; Nubuo Sugo; Tracey Hand; Liejun Wu; Patricia D Hurn; Richard J Traystman; Katrin Andreasson
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

10.  Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex.

Authors:  Ho-Joo Lee; Renee N Ertley; Stanley I Rapoport; Richard P Bazinet; Jagadeesh S Rao
Journal:  Neurochem Res       Date:  2007-12-14       Impact factor: 3.996

View more
  5 in total

1.  Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions.

Authors:  Troy C Lund; Amanda Kobs; Bruce R Blazar; Jakub Tolar
Journal:  Cytotherapy       Date:  2010-08-31       Impact factor: 5.414

Review 2.  Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia.

Authors:  Gerwyn Morris; Luba Sominsky; Kenneth R Walder; Michael Berk; Wolfgang Marx; André F Carvalho; Chiara C Bortolasci; Michael Maes; Basant K Puri
Journal:  Mol Neurobiol       Date:  2022-03-26       Impact factor: 5.682

Review 3.  Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level.

Authors:  Caner Gunaydin; S Sirri Bilge
Journal:  Eurasian J Med       Date:  2018-06-01

4.  Age‑dependent alterations in the immunoreactivity of macrophage inflammatory protein‑3α and its receptor CCR6 in the gerbil hippocampus.

Authors:  Ji Hyeon Ahn; Joon Ha Park; Tae-Kyung Lee; Go Eun Yang; Myoung Cheol Shin; Jun Hwi Cho; Moo-Ho Won; Choong-Hyun Lee
Journal:  Mol Med Rep       Date:  2020-06-09       Impact factor: 2.952

5.  Spatial and temporal changes in the PGE2 EP2 receptor in mice hippocampi during postnatal development and its relationship with cyclooxygenase-2.

Authors:  Hyo Young Jung; Woosuk Kim; Kyu Ri Hahn; Sung Min Nam; Sun Shin Yi; Hyun Jung Kwon; Min Soo Kang; Jung Hoon Choi; Dae Won Kim; Yeo Sung Yoon; In Koo Hwang
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.